Articles from Tidepool

Tidepool, a nonprofit organization dedicated to empowering the diabetes community through open-source innovation, proudly announces it has achieved ISO 13485:2016 certification from accredited certification body TÜV SÜD America for its open-source Quality Management System (QMS), known as qmsOS. This significant milestone underscores Tidepool’s commitment to maintaining the highest standard of quality and safety while fostering transparency and accessibility within the industry.

Tidepool, a software company committed to innovations in diabetes management, is thrilled to announce a new data integration with continuous glucose monitoring (CGM) manufacturer Abbott (NYSE: ABT). A major development towards the goal of patient and provider choice, the cloud-to-cloud integration will provide an automatic stream of data from patients using Abbott’s FreeStyle Libre portfolio of CGMs in the U.S. to Tidepool+.

Tidepool, a software company committed to innovations in diabetes management, is thrilled to announce the achievement of SOC 2 Type II compliance in accordance with American Institute of Certified Public Accountants (AICPA) standards for SOC for Service Organizations also known as SSAE 18. Achieving this standard with an unqualified opinion serves as third-party industry validation that Tidepool provides enterprise-level security for customers’ data secured in the Tidepool Data Platform.

Tidepool, a software company committed to innovations in diabetes management, is thrilled to announce the launch of its state-of-the-art Electronic Health Record (EHR) integration for its cutting-edge diabetes data visualization platform. This groundbreaking integration marks a significant advancement in the company’s mission to empower healthcare providers and people living with diabetes to make their data more accessible, actionable, and meaningful.

Tidepool, a 501(c)(3) non-profit organization empowering the next generation of diabetes innovation, today announced that they have secured funding to kick off the development work to support Tidepool Loop on Android devices. Tidepool Loop is an automated insulin dosing app intended for the management of type 1 diabetes in persons six years of age and greater that received 510(k) clearance from the FDA earlier this year. Tidepool Loop is anticipated to launch on Apple devices.

Tidepool, a recognized innovator in the diabetes space, announced the inclusion of Ambulatory Glucose Profile (AGP) reports into the Tidepool Data Platform. The Tidepool Data Platform provides intuitive tracking and visualization of diabetes data for providers, people with diabetes and their care teams.

Tidepool, a 501(c)3 nonprofit committed to empowering the next generation of innovations in diabetes management, today announced the FDA clearance of Tidepool Loop, an automated insulin dosing app intended for the management of type 1 diabetes (T1D) in persons six years of age and greater.

Tidepool, a recognized innovator in the diabetes space driving interoperability for all diabetes software and devices, announced that John Lister, has been appointed to the Tidepool team as Chief Operating Officer. As Tidepool's new COO, John will lead and scale business operations and go-to-market teams, positioning the organization for success utilizing their nimble software-first approach within the medical device industry.

Tidepool, a medical device company fostering the next generation of diabetes innovation, announced the addition of leading experts in the women’s health and endocrinology space as members of the Tidepool Advisory Council - affirming the organization's commitment to championing women’s health and diabetes initiatives. Tidepool originally kicked off the Tidepool Period Project in 2021 with a pilot dedicated to collecting the largest data set of combined diabetes and menstruation data and this move indicates Tidepool will continue to drive innovation in the Women+ & diabetes space.

Tidepool, a 501(c)3 nonprofit committed to providing software at no charge to the diabetes community, has received financial support from Amazon Web Services (AWS) in support of the Tidepool Period Project, a new initiative that strives to address the unmet needs of people with diabetes who menstruate. This funding will support prototype concepts and user interface designs for both the clinician and patient experiences within Tidepool’s digital ecosystem, along with user research with clinicians, researchers, and patients to help set the foundation for future integrations of diabetes and menstrual cycle data.